Brief: Crossject Says Production Of Zeneo Will Resume Early 2019
21/11/2018 18:07
Nov 21 (Reuters) - CROSSJECT SA ALCJ.PA :
* PRODUCTION OF ZENEO TO RESUME EARLY 2019
* EXPECTS MARKETING AUTHORIZATION ISSUED BY THE REGULATORY
AUTHORITIES FROM 2020
* ANTICIPATES THE SIGNING OF LICENSING AGREEMENTS ON 2019
Source text for Eikon: ID:nGNE64kCm6
Further company coverage: ALCJ.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure